NO961797L - Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter - Google Patents
Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytterInfo
- Publication number
- NO961797L NO961797L NO961797A NO961797A NO961797L NO 961797 L NO961797 L NO 961797L NO 961797 A NO961797 A NO 961797A NO 961797 A NO961797 A NO 961797A NO 961797 L NO961797 L NO 961797L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- hco3
- yields
- independent
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Det beskrives anvendelse av forbindelsene med formel (I) : hvor n representerer O eller l, Rlf R2, R3 og R,, som er identiske eller forskjel- lige, representerer uavhengig av hverandre et hyd- rogen eller en alkyl; R5 representer et hydrogen eller et radikal valgt fra alkyl, alkylkarbonyl, alkoksyalkyl, alkoksykar- bonyl, alkoksykarbonylalkyl og karboksyalkyl; R6 representerer hydrogen eller et radikal valgt fra alkyl, fenyl og fenylalkyl; R?» RB °9 R9 representerer uavhengig av hverandre et radikal valgt fra halogen, alkyl, alkyl-substituert med en eller flere halogener, alkoksy, hydroksyl, alkoksykarbonyl og karboksyl; og R10 og RU representerer uavhengig av hverandre hydrogen eller et radikal valgt fra halogen, alkyl, alkyl substituert med en eller flere halogener, alkoksy, hydroksyl, alkoksykarbonyl og karboksyl; enantiomerene og diasterioisomerene derav, og addi- sjonssaltene derav med en farmasøytisk akseptabel base.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9505361A FR2733685B1 (fr) | 1995-05-05 | 1995-05-05 | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961797D0 NO961797D0 (no) | 1996-05-03 |
NO961797L true NO961797L (no) | 1996-11-06 |
Family
ID=9478712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961797A NO961797L (no) | 1995-05-05 | 1996-05-03 | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter |
Country Status (9)
Country | Link |
---|---|
US (1) | US5703118A (no) |
EP (1) | EP0740936A3 (no) |
JP (1) | JPH08301754A (no) |
CN (1) | CN1136920A (no) |
AU (1) | AU5204396A (no) |
CA (1) | CA2175747A1 (no) |
FR (1) | FR2733685B1 (no) |
NO (1) | NO961797L (no) |
ZA (1) | ZA963520B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008208A (en) * | 1995-10-23 | 1999-12-28 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
WO1998017267A1 (en) * | 1996-10-23 | 1998-04-30 | Zymogenetics, Inc. | Compositions and methods for treating bone deficit conditions |
FR2756284B1 (fr) * | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CA2384511A1 (en) * | 1999-08-24 | 2001-03-01 | Virginia Commonwealth University | Substituted chiral allosteric hemoglobin modifiers |
FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
CA2487541A1 (en) | 2002-06-19 | 2003-12-31 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
FI20030030A0 (fi) * | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
US20070259966A1 (en) * | 2004-04-22 | 2007-11-08 | Allos Therapeutics, Inc. | Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of Cancer |
US8349066B2 (en) * | 2006-09-21 | 2013-01-08 | Ppg Industries Ohio, Inc. | Low temperature, moisture curable coating compositions and related methods |
CN101274765B (zh) * | 2007-03-30 | 2011-11-30 | 中国石油化工股份有限公司 | 一种含贵金属的微孔钛硅材料及其制备方法 |
CN104250253B (zh) * | 2014-09-12 | 2017-04-05 | 辽宁大学 | 取代四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338012C (en) * | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
JPH02215778A (ja) * | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | 3,4―ジヒドロ―2h―ベンゾピラン誘導体及びその医薬用途 |
US5099012A (en) * | 1990-12-11 | 1992-03-24 | Eastman Kodak Company | Chroman-2-carboxamide conjugates and their use for treatment of reperfusion injury |
JP3053490B2 (ja) * | 1991-02-25 | 2000-06-19 | 杏林製薬株式会社 | チアゾリジン−2,4−ジオン誘導体とその塩及び製造法 |
FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1995
- 1995-05-05 FR FR9505361A patent/FR2733685B1/fr not_active Expired - Fee Related
-
1996
- 1996-05-02 JP JP8111572A patent/JPH08301754A/ja active Pending
- 1996-05-02 EP EP96400931A patent/EP0740936A3/fr not_active Withdrawn
- 1996-05-03 AU AU52043/96A patent/AU5204396A/en not_active Abandoned
- 1996-05-03 CN CN96104494A patent/CN1136920A/zh active Pending
- 1996-05-03 CA CA002175747A patent/CA2175747A1/fr not_active Abandoned
- 1996-05-03 US US08/643,257 patent/US5703118A/en not_active Expired - Fee Related
- 1996-05-03 NO NO961797A patent/NO961797L/no not_active Application Discontinuation
- 1996-05-03 ZA ZA963520A patent/ZA963520B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2733685A1 (fr) | 1996-11-08 |
EP0740936A2 (fr) | 1996-11-06 |
JPH08301754A (ja) | 1996-11-19 |
EP0740936A3 (fr) | 1997-01-15 |
US5703118A (en) | 1997-12-30 |
CA2175747A1 (fr) | 1996-11-06 |
NO961797D0 (no) | 1996-05-03 |
ZA963520B (en) | 1996-11-13 |
AU5204396A (en) | 1996-11-14 |
CN1136920A (zh) | 1996-12-04 |
FR2733685B1 (fr) | 1997-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
NO20062370L (no) | Amidderivater | |
DE60208568D1 (de) | Prostaglandinanaloga als ep4-rezeptoragonisten | |
EE200900004A (et) | Dopamiini neurotransmissiooni modulaatorid, nende kasutamine ja neid hendeid sisaldavad farmatseutilised kompositsioonid | |
HUP0400636A2 (hu) | Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk | |
DK0794949T3 (da) | Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler | |
BRPI0209216B8 (pt) | derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos | |
SE0104332D0 (sv) | Therapeutic agents | |
CA2449874A1 (en) | New indole derivatives with 5-ht6 receptor affinity | |
NO20085077L (no) | Nye forbindelser | |
NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
MXPA04007414A (es) | Indoles sustituidos como agonistas alfa-1. | |
NO20073357L (no) | 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien | |
HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
CA2114593A1 (fr) | Derives de l'indole de l'indazole et du benzisoxazo le, leur procede de preparation et les compositions pharmace utiques qui les contiennent | |
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
NO20052730L (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
NO20015172L (no) | 1-metyl-erytromycin-derivater | |
NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
DK0607193T3 (da) | Antifugale triazolderivater | |
NO961797L (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
NO20040589L (no) | Arylsulfonylderivater med 5-HT6 reseptor affinitet. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |